CHEMISTS' OWN LACTULOSE 667 mg/mL oral liquid bottle

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

lactulose, Quantity: 667 mg/mL

Disponible depuis:

Arrotex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

Lactulose

forme pharmaceutique:

Oral Liquid

Composition:

Excipient Ingredients:

Mode d'administration:

Oral

Unités en paquet:

500 mL

Type d'ordonnance:

Not scheduled. Not considered by committee

indications thérapeutiques:

Treatment of acute, and prevention and treatment of chronic portal-systemic encephalopathy (PSE), including the stages of hepatic pre-coma and coma.,Treatment of chronic and habitual constipation.,Where a soft stool is considered of medical benefit (haemorrhoids, post-colonic/anal surgery).

Descriptif du produit:

Visual Identification: Clear, colourless to brownish-yellow, viscous liquid.; Container Type: Bottle; Container Material: Polyethylene Terephthalate; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-02-13